Is there an association between haemoglobin, depression, and anxiety in cancer patients?

被引:24
作者
Skarstein, J
Bjelland, I
Dahl, AA
Laading, J
Fosså, SD
机构
[1] Univ Oslo, Dept Clin Canc Res, Norwegian Radium Hosp, N-0310 Oslo, Norway
[2] Norwegian Comp Ctr, Dept Appl Res & Dev, Oslo, Norway
[3] Univ Oslo, Norwegian Radium Hosp, Dept Med Oncol & Radiotherapy, Oslo, Norway
[4] Univ Oslo, Norwegian Radium Hosp, Dept Psychosocial Oncol, Oslo, Norway
[5] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway
关键词
cancer patients; haemoglobin; depression; anxiety; hospital anxiety and depression scale;
D O I
10.1016/j.jpsychores.2005.02.003
中图分类号
R749 [精神病学];
学科分类号
100205 [精神病与精神卫生学];
摘要
Objective: The aim of this study was to examine the association between haemoglobin levels, anxiety disorder, and depression in cancer patients. Methods: Cancer patients attending The Norwegian Radium Hospital (NRH) rated themselves on the Hospital Anxiety and Depression Scale (HADS). Five hundred thirty-two patients also had valid measurements of haemoglobin at the same time. The associations between tertile baemoglobin levels (7.0-12.3 g/dl, 12.4-13.8 g/dl, 13.9-17.1 g/dl) and HADS-defined anxiety disorder and depression were analysed by logistic regression. Results: HADS-defined depression was identified in 116 cases (22%) and anxiety disorder in 149 (28%). The haemoglobin levels of the lower and middle tertiles were associated with depression (OR=3.85, 95% CI: 2.06-7.21, and OR=2.45, 95% CI: 1.25-4.81, respectively). Adjustment for covariates did not change the association significantly. No association between haemoglobin and anxiety disorder was found. Conclusion: In cancer patients, the risk of depression increases with decreasing haemoglobin levels. This should be taken into account when treatment of anaemic or depressed cancer patients is decided upon. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:477 / 483
页数:7
相关论文
共 35 条
[1]
THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]
Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital [J].
Aass, N ;
Fossa, SD ;
Dahl, AA ;
Moe, TJ .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) :1597-1604
[3]
BJELLAND I, 2002, J PSYCHOSOM RES, V0052
[4]
PSYCHOMETRIC VALIDATION OF THE EORTC CORE QUALITY-OF-LIFE QUESTIONNAIRE, 30-ITEM VERSION AND A DIAGNOSIS-SPECIFIC MODULE FOR HEAD AND NECK-CANCER PATIENTS [J].
BJORDAL, K ;
KAASA, S .
ACTA ONCOLOGICA, 1992, 31 (03) :311-321
[5]
Bottomley A, 2001, ESO SCI UPDATES, V6, P55
[6]
Bottomley A, 1998, Eur J Cancer Care (Engl), V7, P181
[7]
The effect of epoetin alfa on quality of life in anemic cancer patients [J].
Cella, D ;
Bron, D .
CANCER PRACTICE, 1999, 7 (04) :177-182
[8]
Epoetin beta - A review of its clinical use in the treatment of anaemia in patients with cancer [J].
Cheer, SM ;
Wagstaff, AJ .
DRUGS, 2004, 64 (03) :323-346
[9]
Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study [J].
Demetri, GD ;
Kris, M ;
Wade, J ;
Degos, L ;
Cella, D .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3412-3425